We studied the effects of two xanthones compounds isolated from Swertia punicea Hemsl (from Geutianaceae), swertianolin (I) and bellidifolin (II), on Hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in cultured human hepatocellular carcinoma cell line (HepG 2 ). The HepG 2 cells were first cultured for 24h, various concentrations of these two xanthones were then added to the culture medium. The culture medium containing the two xanthones was exchanged once every 4 days. After 8 days, the cytotoxic activities of these two xanthones were assessed by cytopathic effect. The HepG 2 cells were then treated with the two compounds at a concentration of swertianolin (1.6, 3.1, 6.2, 12.5, 25g/ml) and bellidifolin (2.0, 3.9, 7.8, 25.5, 31.2g/ml). Four or eight days later, the culture medium was collected and the expression of HBsAg and HBeAg were determined by radioimmunoassay. Our results show that swertianolin can suppress the expression of HBeAg with IC 50 of 8.0g/ml, while bellidifolin can inhibit the expression of HBsAg with IC 50 of 13g/ml at the eighth days. The Therapeutic Index for swertianolin and bellidifolin are 6.2 and 6.8, respectively. Our findings suggest that swertianolin and bellidifolin have anti-HBV activities in vitro.
INTRODUCTION
Hepatitis B is one of the most prevalent infectious diseases, especially in Asia. It has been reported that more than 350 million people worldwide are persistent carriers of HBsAg. 1, 2 Infection with hepatitis B virus (HBV) results in severe liver diseases, including chronic hepatitis, cirrhosis and hepatocelluer carcinoma. 3 At present, interferon-α and lamivudine are the main licensed drugs for the treatment of chronic HBV infection. However, interferon-α is expensive and is associated with severe side effects. Long-term treatment with lamivudine may cause drug resistance. 4 Therefore, the development of more effective agents from crude extracts with anti-HBV activity remains of great importance. Swertia punicea Hemsl (from Geutianaceae) is a traditional medicinal plant mainly used for the treatment of hepatitis in some rural areas in China, and it has been approved for pharmacological and clinical trials in Hubei and Yunnan province in China. It has been reported that some of its active components, such as oleanolic acid, mangiferin, and swertiamarin, are useful for the treatment of liver diseases. [5] [6] [7] [8] [9] The HepG 2 cells has been developed as a model for screening novel agent with anti-HBV biological activities. 10, 11 In this study, we reported that two active components isolated from the Chinese herb, Swertia punicea Hemsl, suppressed HBsAg or HBeAg the expression of the HepG 2 cells. The structures of these two components were identified as xanthones, namely, swertianolin (I) and bellidifolin (II). 
METHODS

Plant Collection and Identification
Preparation of Tested Compounds
The plant materials were air-dried and ground to a fine powder. Extraction was performed by soaking samples (500g dry weight) in 95% ethanol (5000ml) for 24h at 25º C. After filtration through filter paper, the residue was washed twice with 95% ethanol, followed by concentrating in vacuum at 40º C. The extract was further extracted with petroleum ether for 5 times to remove chlorophyll and subsequently partitioned in ether, EtOAc and water. The aqueous and EtOAc extractions were fractionated by chloroform and methanol gradient of sequential gel column chromatograph, respectively. The two compounds were obtained in chloroform and methanol (90:10 and 75:25, v:v) and further
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purified by SephadexLH-20 column chromatography. The structures of the two compounds were identified respectively by comparing 1 H-NMR, 13 C-NMR and MS data with literature. For bioassay, the two compounds were first dissolved in Dimethyl sulfoxide (DMSO), and then filtered through 0.45μm filter.
Reagents and Chemicals
HBsAg and HBeAg radioimmunoassay kits were purchased from the Chinese Isotope Co. (Beijing, China). Dulbecco's modified Eagle's medium (DMEM) and L-glutamine were obtained from Gibco Industries Inc. (Los Angeles, CA, USA). Fetal Bovine serum (FBS) was obtained from Hyclone (Logan, UT, USA). DMSO was obtained from Sigma (Dorset, UK). All chemical reagents for chromatography were of HPLC grade.
Cell Culture
HepG 2 cells were obtained from the Mount Sinai School of Medicine, USA, and were maintained in DMEM medium supplemented with 10% FBS, 50U/ml streptomycin and 3% L-glutamine. The cells were seeded into 96-well plates at a density of 2.0×10 4 /well, and incubated in 5% CO 2 at 37℃ for 24h. Various concentrations of the two xanthones were then added to the culture medium. The medium was removed every 4 days and fresh medium was added.
Cytotoxic Activity Assay
After 8 days, the viability of the cells was assesssed by cytopathic effect. The median toxic concentration (TC 50 ) values were calculated according to the method of ReedMeuench.
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Determination of HBsAg and HBeAg
After the cytotoxic activity assay of these two xanthones, the HepG 2 cells were seeded into 24-well plates at a density of 1.0×10 5 /well and allowed to attach overnight. The medium was changed to DMEM without serum, HepG 2 cells were treated with the two compounds at a concentration of swertianolin (1.6, 3.1, 6.2, 12.5, 25g/ml) and bellidifolin (2.0, 3.9, 7.8, 25.5, 31.2g/ml). The medium was removed every 4 days and fresh medium containing the two compounds was added until the eighth day. The culture medium of the fourth and eighth days was collected. The HBsAg and HBeAg in culture medium, which was secreted by HepG 2 cells, was measured by a radioimmunoassay kit according to the manufacture's instructions (Chinese Isotope Co.) and counted in a hemocytometer. The mean value (x) of cycles per minute (cpm) and standard deviation (s) of both experimental and control groups were calculated. The assays were performed in triplicate and the results were averaged. The antigen inhibition percentage (%) between the experimental group and the control group, the half maximal inhibitory concentration (IC 50 ), and therapeutic index (TI) were all calculated. The difference in cpm between the experimental and control groups were calculated using the Student's test. 
RESULTS
Screening of Active Substances
In the course of our search for natural plant products as anti-HBV agents, the aqueous and EtOAc extracts of Swertia punicea Hemsl were found to show significant anti-HBV activity in vitro. Subsequent bioactivity fractionation resulted in the isolation of two pure compounds as the active compounds. The structures of these two active compounds were identified as swertianolin (I) and bellidifolin (II), respectively (Figure 2 ).
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Figure 2. The structural formula of swertianolin and bellidifolin.
Cytotoxicity of the Two Compounds
We assessed the cytotoxicity of these two compounds by cytopathic effect, and found that TC 50 of swertianolin and bellidifolin were 50μg/ml and 88μg/ml, respectively.
Suppression of HBsAg and HBeAg Production in HepG2
We assessed the effect of these two compounds on HBsAg and HBeAg production in HepG2 cells at the fourth and eighth days in culture. At the fourth day, IC 50 of bellidifolin and swertianolin suppressing HBsAg or HBeAg expression of the HepG 2 cells could not calculated according to the experimental results. But the results from the eighth day showed that bellidifolin effectively suppressed HBsAg expression of the HepG 2 cells with IC 50 of 13μg/ml and TI of 6.8. Swertianolin inhibited HBeAg expression with IC 50 of 8.0μg/ml and TI of 6.2. The suppression on HBsAg and HBeAg expression of swertianolin and bellidifolin was not due to any cytotoxic activity of these two compounds, since the treated cells were still viable and continued to proliferate slowly during the incubation period of 8 days ( Table 1 and  Table 2 ). 
DISCUSSION
Hepatitis B infection is a major health concern worldwide, especially in Asia. As a consequence, there is an increasing interest in the anti-HBV activities of natural products from Chinese herbs. Swertia punicea Hemsl is a traditional Chinese medicinal herb which has been used widely for many diseases including hepatitis for a long time. In this study, we isolated and identified two active xanthones from Swertia punicea Hemsl, which showed significant suppression effects on the expression of HBsAg or HBeAg in human hepatocellular carcinoma HepG 2 cells in culture. These two xanthones were identified as swertianolin and bellidifolin by analysis of the spectral data. Furthermore, we show for the first time that these two natural products from Swertia punicea Hemsl exhibit anti-HBV activities in vitro and this property may partly explain the reported effects of this medicinal plant in clinical application. 9 Therefore, our findings suggest that swertianolin and bellidifolin may possess potential in the development of effective anti-HBV drugs in the future. 
